What is the project about?
This Commonwealth funded evaluation study is being conducted by a team of researchers. The evaluation brings together 3 kidney health programs:
CD-IMPACT in Western Health Melbourne, Victoria
Territory Kidney Care (TKC) in the Northern Territory
CKD.TASlink in Tasmania
Each of these kidney health programs has been developed and implemented over the past few years and now, evaluation is being undertaken by Menzies School of Health Research in partnership with Western Health Melbourne and University of Tasmania.
Who are the people involved in the evaluation?
Lead Investigators from the CKD Consortium include A/Prof Craig Nelson (Western Health, Melbourne), Professor Paul Lawton (Alfred Health), Professor Matthew Jose (University of Tasmania/ Royal Hobart Hospital), Professor Alan Cass (Menzies School of Health Research), Dr Asanga Abeyaratne (NT Renal Services, Darwin). A project team led by Dr Gillian Gorham, Head Renal Research Program, will be based at Menzies School of Health Research and lead the evaluation study.
What are the anticipated outcomes?
The evaluation will compare the identification and management of Chronic Kidney Disease (CKD) in primary care of Victoria (VIC), Northern Territory (NT) and Tasmania (TAS) as per the national guidelines (e.g. Kidney Health Australia) and consider the benefits of outputs of clinical decision systems, assess effect on health outcomes of patients, changes in health service utilization and financial sustainability.
The researchers are inviting everyone who used/received outputs of CD-IMPACT/Territory Kidney Care/CKD Taslink to tell them about their experience. The CKD Consortium would like feedback on what are the programs’ good points AND their bad points! The researchers would like to hear from the previous programs’ participants in 2 ways – by filling in a short survey and/or taking part in an interview.
